Quipt Home Medical Corp QIPT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if QIPT is a good fit for your portfolio.
News
-
Quipt Home Medical Announces Voting Results from Its Annual General and Special Meeting of Shareholders
-
Quipt Home Medical Announces Participation in the 36th Annual Roth Investor Conference on March 17-19, 2024
-
Quipt Home Medical Reports Strong Operating Performance With Record First Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 60% and Adjusted EBITDA Growth of 71%
-
Quipt Home Medical Corp. to Announce Fiscal First Quarter 2024 Financial Results on February 14, 2024
Trading Information
- Previous Close Price
- $3.85
- Day Range
- $3.79–3.87
- 52-Week Range
- $3.42–6.63
- Bid/Ask
- $3.78 / $3.79
- Market Cap
- $161.13 Mil
- Volume/Avg
- 18,733 / 136,136
Key Statistics
- Price/Earnings (Normalized)
- 45.01
- Price/Sales
- 0.62
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,100
- Website
- https://www.quipthomemedical.com
Comparables
Valuation
|
Metric
|
QIPT
|
7749
|
MMSI
|
|---|---|---|---|
Price/Earnings (Normalized) | 45.01 | 17.59 | 24.64 |
Price/Book Value | 1.47 | 1.03 | 3.57 |
Price/Sales | 0.62 | 2.23 | 3.44 |
Price/Cash Flow | 3.24 | 10.41 | 20.12 |
Price/Earnings
QIPT
7749
MMSI
Financial Strength
|
Metric
|
QIPT
|
7749
|
MMSI
|
|---|---|---|---|
Quick Ratio | 0.73 | 6.53 | 3.81 |
Current Ratio | 1.13 | 7.52 | 5.45 |
Interest Coverage | 0.53 | 603.83 | 8.07 |
Quick Ratio
QIPT
7749
MMSI
Profitability
|
Metric
|
QIPT
|
7749
|
MMSI
|
|---|---|---|---|
Return on Assets (Normalized) | 1.23% | 8.65% | 9.43% |
Return on Equity (Normalized) | 2.70% | 9.74% | 14.77% |
Return on Invested Capital (Normalized) | 5.69% | 9.73% | 11.47% |
Return on Assets
QIPT
7749
MMSI
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Sxgjblmpj | Jyckw | $185.8 Bil | |
SYK
| Stryker Corp | Pnqmnfrzmb | Cvpzw | $127.4 Bil | |
MDT
| Medtronic PLC | Xbrdsxjz | Srvkcf | $105.2 Bil | |
BSX
| Boston Scientific Corp | Nddmryd | Yrrdy | $99.0 Bil | |
DXCM
| DexCom Inc | Jrhwpzkcf | Prl | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Mqsyyszh | Rgkkb | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Ndzlbvxcs | Krt | $25.0 Bil | |
ALGN
| Align Technology Inc | Hdlwnzjf | Byxlx | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Jtjxjkxt | Mjwqwz | $18.9 Bil | |
PODD
| Insulet Corp | Gvyjdvyvw | Jvwtttd | $11.7 Bil |